Koninklijke Philips NV (PHG)
32.73
+1.16
(+3.67%)
USD |
NYSE |
Sep 27, 16:00
32.73
0.00 (0.00%)
After-Hours: 18:32
Koninklijke Philips Cash and Short Term Investments (Quarterly)
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.069B |
| June 30, 2023 | 1.052B |
| December 31, 2022 | 1.269B |
| June 30, 2022 | 1.322B |
| December 31, 2021 | 2.610B |
| June 30, 2021 | 1.194B |
| December 31, 2020 | 3.968B |
| June 30, 2020 | 2.580B |
| December 31, 2019 | 1.597B |
| June 30, 2019 | 1.766B |
| December 31, 2018 | 2.430B |
| June 30, 2018 | 1.868B |
| December 31, 2017 | 2.329B |
| September 30, 2017 | 1.179B |
| June 30, 2017 | 2.540B |
| March 31, 2017 | 3.022B |
| December 31, 2016 | 2.574B |
| September 30, 2016 | 2.201B |
| June 30, 2016 | 2.259B |
| March 31, 2016 | 1.583B |
| December 31, 2015 | 1.944B |
| September 30, 2015 | 1.168B |
| June 30, 2015 | 1.278B |
| March 31, 2015 | 1.941B |
| December 31, 2014 | 2.430B |
| Date | Value |
|---|---|
| September 30, 2014 | 2.337B |
| June 30, 2014 | 2.128B |
| March 31, 2014 | 2.390B |
| December 31, 2013 | 3.418B |
| September 30, 2013 | 2.758B |
| June 30, 2013 | 3.008B |
| March 31, 2013 | 3.930B |
| December 31, 2012 | 5.070B |
| September 30, 2012 | 4.173B |
| June 30, 2012 | 3.899B |
| March 31, 2012 | 5.625B |
| December 31, 2011 | 4.076B |
| September 30, 2011 | 3.177B |
| June 30, 2011 | 4.720B |
| March 31, 2011 | 6.738B |
| December 31, 2010 | 7.758B |
| September 30, 2010 | 5.975B |
| June 30, 2010 | 5.494B |
| March 31, 2010 | 5.926B |
| December 31, 2009 | 6.272B |
| September 30, 2009 | 5.471B |
| June 30, 2009 | 5.038B |
| March 31, 2009 | 5.297B |
| December 31, 2008 | 5.059B |
| September 30, 2008 | 3.463B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.052B
Minimum
Jun 2023
3.968B
Maximum
Dec 2020
1.962B
Average
1.597B
Median
Dec 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Trinity Biotech PLC | 5.317M |
| Adaptimmune Therapeutics PLC | 214.79M |
| argenx SE | 3.102B |
| NewAmsterdam Pharma Co NV | 430.71M |
| uniQure NV | 524.43M |